Asia Morning: US Stocks Surge on Virus Vaccine Hopes

On Monday, U.S. stocks soared after Drug-maker Moderna reported positive results for a coronavirus vaccine trial...

Trading floor 2

On Monday, U.S. stocks soared after Drug-maker Moderna (MRNA +19.96%) reported positive results for a coronavirus vaccine trial.

While lockdowns continued to ease nationwide, market sentiment was also boosted by U.S. Federal Reserve Chairman Jerome Powell's comments over the weekend that the central bank still had tools to support the economy.

The Dow Jones Industrial Average surged 912 points (+3.9%) to 24597, the S&P 500 jumped 90 points (+3.2%) to 2953, and the Nasdaq 100 was up 179 points (+2.0%) to 9331.


Source: GAIN Capital, TradingView

Automobiles & Components (+9.23%), Energy (+7.55%) and Banks (+7.18%) sectors performed the best.

Stocks in travel-related sectors such as Norwegian Cruise Line (NCLH +17.95%), United Airlines (UAL +21.13%) and Expedia (EXPE +18.62%) were top gainers within the S&P 500.

General Motors (GM +9.63%), Ford (F +8.37%), Best Buy (BBY +10.88%) and FedEx (FDX +10.85%) also gained big.

On the technical side, about 26.2% (26.6% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average, and 38.6% (37.8% in the prior session) were above their 20-day moving average.

Later today, U.S. official data on Housing Starts for April (a decline to an annualized rate of 904,000 units expected) will be released.

European stocks also saw beefy gains, with the Stoxx Europe 600 Index surging 4.1%. Germany's DAX soared 5.7%, France's CAC jumped 5.2%, and the U.K.'s FTSE 100 was up 4.3%.

U.S. Treasury prices eased further, as the benchmark 10-year Treasury yield advanced to 0.741% from 0.640% Friday, the highest level in over five weeks.

Spot gold price halted a four-session rally as it retreated 10 dollars (-0.6%) to $1,730 an ounce.

Oil prices kept showing upward momentum, as U.S. WTI crude oil futures (June) charged 8.1% higher to $31.82 a barrel.

On the forex front, the ICE U.S. Dollar Index slid 0.8% on day to 99.62, while promising trial results from Moderna's coronavirus vaccine lifted investors' risk appetite.

More from Indices

Related Articles

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.